Your browser doesn't support javascript.
loading
A Phase 1b/2a Study of GC1118 with 5-Fluorouracil, Leucovorin and Irinotecan (FOLFIRI) in Patients with Recurrent or Metastatic Colorectal Cancer.
Lee, Keun-Wook; Han, Sae-Won; Kim, Tae Won; Ahn, Joong Bae; Baek, Ji Yeon; Cho, Sang Hee; Lee, Howard; Kim, Jin Won; Kim, Ji-Won; Kim, Tae-You; Hong, Yong Sang; Beom, Seung-Hoon; Cha, Yongjun; Choi, Yoonjung; Kim, Seonhui; Bang, Yung-Jue.
Affiliation
  • Lee KW; Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Korea.
  • Han SW; Department of Internal Medicine, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea.
  • Kim TW; Seoul National University Cancer Research Institute, Seoul, Korea.
  • Ahn JB; Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
  • Baek JY; Division of Medical Oncology, Department of Internal Medicine, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Korea.
  • Cho SH; Center for Colorectal Cancer, Research Institute and Hospital, National Cancer Center, Goyang, Korea.
  • Lee H; Division of Hemato-Oncology, Department of Internal Medicine, Chonnam National University Hwasun Hospital, Chonnam National University Medical School, Hwasun, Korea.
  • Kim JW; Department of Clinical Pharmacology and Therapeutics, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea.
  • Kim JW; Department of Molecular Medicine and Biopharmaceutical Sciences, Graduate School of Convergence Science and Technology, Seoul National University, Seoul, Korea.
  • Kim TY; Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Korea.
  • Hong YS; Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Korea.
  • Beom SH; Department of Internal Medicine, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea.
  • Cha Y; Seoul National University Cancer Research Institute, Seoul, Korea.
  • Choi Y; Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
  • Kim S; Division of Medical Oncology, Department of Internal Medicine, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Korea.
  • Bang YJ; Center for Colorectal Cancer, Research Institute and Hospital, National Cancer Center, Goyang, Korea.
Cancer Res Treat ; 56(2): 590-601, 2024 Apr.
Article in En | MEDLINE | ID: mdl-38062706
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Rectal Neoplasms / Colorectal Neoplasms / Colonic Neoplasms / Antibodies, Monoclonal, Humanized Limits: Humans Language: En Journal: Cancer Res Treat Year: 2024 Document type: Article
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Rectal Neoplasms / Colorectal Neoplasms / Colonic Neoplasms / Antibodies, Monoclonal, Humanized Limits: Humans Language: En Journal: Cancer Res Treat Year: 2024 Document type: Article